“…To study the pharmacokinetics of nine compounds (baicalin, baicalein, wogonoside, wogonin, scutellarin, berberine, coptisine, the ginsenoside Rb1 and ginsenoside Re) in vivo , several analytical methods have been established by HPLC (Li, Zhang, et al, ; Tsai & Tsai, ), UPLC (Chen, Li, et al, ), LC–MS (Xia et al, ; Zhu et al, ), UPLC–MS (Joo et al, ), LC–MS/MS (Feng et al, ; Tong et al, ; Zhang, Ma, Liu, Jiang, & Wang, ; Zhao et al, ) and UPLC–MS/MS (Cui et al, ; Qian et al, ). A pharmacokinetic study of the constituents in one of the composition herbs in BXD has been reported (Wang et al, ), but there are few reports on pharmacokinetic studies of the nine active components after administration of BXD in rats simultaneously.…”